Literature DB >> 17475321

Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells.

Markus Elfinger1, Christof Maucksch, Carsten Rudolph.   

Abstract

In this study lactoferrin (Lf) was investigated as a targeting ligand for receptor-mediated gene delivery to human bronchial epithelial cells. A high number of lactoferrin receptors (LfRs) were detected on bronchial epithelial (BEAS-2B), but not on alveolar epithelial (A549) cells by fluorescence microscopy and FACS measurements, suggesting potential targeting selectivity for bronchial epithelial cells. Molecular conjugates with ratios of Lf to branched polyethylenimine 25 kDa (PEI) ranging from 4:1 to 1:40 (mol/mol) were synthesized and analyzed for complexation of plasmid DNA (pDNA), transfection efficiency, and cytotoxicity. Whereas particle size increased with the degree of Lf coupling from 45 to 225 nm, surface charge was not significantly influenced. Transfection studies on BEAS-2B cells revealed that Lf-PEI 1:20 exhibited the highest luciferase gene expression which was 5-fold higher at an N/P ratio (molar ratio of PEI nitrogen to pDNA phosphate) of 4 than PEI and could be inhibited by an excess of free Lf. With A549 cells, no significant enhancement in transfection efficiency between Lf-PEI/pDNA and PEI/pDNA complexes could be observed. Increasing the degree of Lf coupling to PEI resulted in reduced transfection efficiency in both alveolar and bronchial epithelial cells. Cell viability assays resulted in significantly lower cellular toxicity of Lf-PEI/pDNA compared with PEI/pDNA complexes. We suggest that Lf represents a potent targeting ligand for receptor-mediated gene delivery to bronchial epithelial cells and might be a promising candidate for lung gene transfer in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475321     DOI: 10.1016/j.biomaterials.2007.04.011

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  23 in total

1.  Enhanced lentiviral vector production in 293FT cells expressing Siglec-9.

Authors:  Toru Shoji; Hiroshi Higuchi; Yoshinori Zaitsu; Ken-Ichi Nishijima; Shinji Iijima
Journal:  Cytotechnology       Date:  2014-01-25       Impact factor: 2.058

2.  Investigation of the "Nose-to-Brain" Pathways in Intranasal HupA Nanoemulsions and Evaluation of Their in vivo Pharmacokinetics and Brain-Targeting Ability.

Authors:  Yueyao Jiang; Yichuan Jiang; Zhiying Ding; Qian Yu
Journal:  Int J Nanomedicine       Date:  2022-08-04

Review 3.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

4.  Allergen particle binding by human primary bronchial epithelial cells is modulated by surfactant protein D.

Authors:  Carsten Schleh; Veit J Erpenbeck; Carla Winkler; Hans D Lauenstein; Matthias Nassimi; Armin Braun; Norbert Krug; Jens M Hohlfeld
Journal:  Respir Res       Date:  2010-06-22

5.  A potential targeting gene vector based on biotinylated polyethyleneimine/avidin bioconjugates.

Authors:  Xuan Zeng; Yun-Xia Sun; Xian-Zheng Zhang; Si-Xue Cheng; Ren-Xi Zhuo
Journal:  Pharm Res       Date:  2009-06-05       Impact factor: 4.200

6.  The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route.

Authors:  Yueyao Jiang; Chenqi Liu; Wanchen Zhai; Ning Zhuang; Tengfei Han; Zhiying Ding
Journal:  Int J Nanomedicine       Date:  2019-11-27

7.  Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment.

Authors:  Qiang Wang; Jing Wang; Jiayou Wang; Xiaoli Ju; Heng Zhang
Journal:  Toxicol Res (Camb)       Date:  2021-11-26       Impact factor: 3.524

8.  Structural characterization of the interaction of human lactoferrin with calmodulin.

Authors:  Jessica L Gifford; Hiroaki Ishida; Hans J Vogel
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

9.  Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes.

Authors:  Li Ying Lim; Pei Yin Koh; Sukrut Somani; Majed Al Robaian; Reatul Karim; Yi Lyn Yean; Jennifer Mitchell; Rothwelle J Tate; RuAngelie Edrada-Ebel; David R Blatchford; Margaret Mullin; Christine Dufès
Journal:  Nanomedicine       Date:  2015-04-29       Impact factor: 5.307

10.  Polyethylenimine-mediated gene delivery to the lung and therapeutic applications.

Authors:  Sante Di Gioia; Massimo Conese
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.